Superoxide Dismutase as an Intervention for Radiation Therapy-Associated Toxicities: Review and Profile of Avasopasem Manganese as a Treatment Option for Radiation-Induced Mucositis
Open Access
- 1 March 2021
- journal article
- review article
- Published by Taylor & Francis in Drug Design, Development and Therapy
- Vol. ume 15, 1021-1029
Abstract
Toxicities associated with radiation therapy are common, symptomatically devastating, and costly. The best chance to effectively mitigate radiation-associated normal tissue side effects are interventions aimed at disrupting the biological cascade, which is the basis for toxicity development, while simultaneously not reducing the beneficial impact of radiation on tumor. Oxidative stress is a key initiator of radiation-associated normal tissue injury as physiologic antioxidant mechanisms are overwhelmed by the accumulation of effects produced by fractionated treatment regimens. And fundamental to this is the generation of superoxide, which is normally removed by superoxide dismutases (SODs). Attempts to supplement the activity of endogenous SOD to prevent radiation-induced normal tissue injury have included the administration of bovine-derived SOD and increasing SOD production using gene transfer, neither of which has resulted in a clinically acceptable therapy. A third approach has been to develop synthetic small molecule dismutase mimetics. This approach has led to the creation and development of avasopasem manganese, a unique and specific dismutase mimetic that, in clinical trials, has shown promising potential to reduce the incidence, severity and duration of severe oral mucositis amongst patients being treated with concomitant chemoradiation for cancers of the head and neck. Further, avasopasem and related analogues have demonstrated mechanism-related antitumor synergy in combination with high dose per fraction radiotherapy, an observation that is also being tested in clinical trials. An ongoing Phase 3 trial seeks to confirm avasopasem manganese as an effective intervention for severe oral mucositis associated with chemoradiation in head and neck cancer patients.Keywords
This publication has 53 references indexed in Scilit:
- Ionizing radiation-induced metabolic oxidative stress and prolonged cell injuryCancer Letters, 2012
- A Phase I Study of Concurrent Chemotherapy (Paclitaxel and Carboplatin) and Thoracic Radiotherapy with Swallowed Manganese Superoxide Dismutase Plasmid Liposome Protection in Patients with Locally Advanced Stage III Non-Small-Cell Lung CancerHuman Gene Therapy, 2011
- The manganese superoxide dismutase mimetic, M40403, protects adult mice from lethal total body irradiationFree Radical Research, 2010
- NADPH oxidase mediates radiation-induced oxidative stress in rat brain microvascular endothelial cellsFree Radical Biology and Medicine, 2008
- Efficacy of Superoxide Dismutase Mimetic M40403 in Attenuating Radiation-Induced Oral Mucositis in HamstersClinical Cancer Research, 2008
- On the selectivity of superoxide dismutase mimetics and its importance in pharmacological studiesBritish Journal of Pharmacology, 2003
- Sod mimetics are coming of ageNature Reviews Drug Discovery, 2002
- Targeting Sod by Gene and Protein Engineering and Inhibition of Free Radical InjuryFree Radical Research Communications, 1991
- Radioprotection of mice by superoxide dismtuaseBiochemical and Biophysical Research Communications, 1975
- Biological protection by superoxide dismutaseBiochemical and Biophysical Research Communications, 1973